Präoperative Diagnostik

  • R. Kreienberg
  • T. Volm
  • T. Beck
Part of the Onkologie Aktuell book series (ONKAKTUELL)

Zusammenfassung

Zum Zeitpunkt der Diagnose befinden sich 80–90% aller Patientinnen mit Brustkrebs in einem operablen und 10–20% der Patientinnen in einem lokal fortgeschrittenen, inoperablen oder metastasierten Stadium.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Howe JR, Monsees B, Destouet J, Seib J, Dehner LP, Kraybil WG (1995) Needle localization breast biopsy: A model for multi-disciplinary quality assurance. J Surg Oncol 58: 233–239PubMedCrossRefGoogle Scholar
  2. Morrow M (1995) When can stereotactic core biopsy replace excisional biopsy? A clinical perspective. Breast Cancer Res Treat 36:1–9PubMedCrossRefGoogle Scholar
  3. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohi-stochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–40PubMedGoogle Scholar
  4. Veronesi U, Volterani F, Luini A et al. (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Europ J Cancer 26: 671CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • R. Kreienberg
  • T. Volm
  • T. Beck

There are no affiliations available

Personalised recommendations